Loading organizations...
Nexus Medical Partners operates as a global private equity firm, making strategic equity investments across medical technology, life science, advanced materials, software, and IT sectors. The firm identifies enterprises with robust technology or distinctive business strategies, managing multiple investment funds. It deploys capital and expertise across North America and Europe, fostering portfolio development.
Co-founded in 2004 by Edwin Snape, PhD, and John F. Rousseau, Jr., the firm later evolved into NMT Capital. Their insight stemmed from six decades of combined private equity and M&A experience. Both leaders leveraged extensive backgrounds in investment, operations, and legal practice within healthcare, shaping a hands-on philosophy.
Nexus Medical Partners partners with diverse portfolio companies, providing strategic assistance throughout their growth. The firm’s core mission is to generate enduring value by facilitating access to capital, technology, and partnerships. It actively supports companies in team building and market navigation, guiding them towards significant operational milestones and successful market positions.
Nexus Medical Partners has 1 tracked investment across 1 company. The latest tracked deal is $33.0M Series D in MyoScience in March 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 21, 2012 | MyoScience | $33.0M Series D | — | Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Medicis Capital, Saratoga Ventures, Valiance |